Clinical Trial Update: Clinical Trial to Investigate CT38 in the Treatment of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial investigating CT38 for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome has completed Phase 1 and Phase 2 with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatigue Syndrome
• Myalgic Encephalomyelitis

Drugs mentioned

• CT38

Snippet

Sponsor: LUCINDA BATEMAN, MD | Conditions: Myalgic Encephalomyelitis, Chronic Fatigue Syndrome | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-04-30